AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.085
+0.035 (3.33%)
At close: Jul 2, 2025, 4:00 PM
1.080
-0.005 (-0.46%)
After-hours: Jul 2, 2025, 4:04 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $32.74 million as of July 2, 2025. Its market cap has decreased by -44.84% in one year.
Market Cap
32.74M
Enterprise Value
-34.44M
1-Year Change
-44.84%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $32.74M, a decrease of -88.35%. That is a compound annual growth rate of -48.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 31.68M | -23.16% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |